Exelixis (NASDAQ:EXEL) Announces Earnings Results
Exelixis (NASDAQ:EXEL – Get Free Report) announced its earnings results on Tuesday. The biotechnology company reported $0.40 EPS for the quarter, topping the consensus estimate of $0.36 by $0.04, Zacks reports. The company had revenue of $539.50 million for the quarter, compared to analysts’ expectations of $490.31 million. Exelixis had a net margin of 22.43% […]
1 Nov 20:14 · The Markets Daily